Jasper Therapeutics' valuation falls to $53M following drug development issues, leading to layoffs and a focus shift to ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.